HIV and aging

State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group

Kevin P. High, Mark Brennan-Ing, David B. Clifford, Mardge H. Cohen, Judith Currier, Steven G. Deeks, Sherry Deren, Rita B. Effros, Kelly Gebo, Jörg J. Goronzy, Amy C. Justice, Alan Landay, Jules Levin, Paolo G. Miotti, Robert J. Munk, Heidi Nass, Charles R. Rinaldo, Michael G. Shlipak, Russell Tracy, Victor Valcour & 3 others David E. Vance, Jeremy D Walston, Paul Volberding

Research output: Contribution to journalArticle

Abstract

HIV risk behaviors, susceptibility to HIV acquisition, progression of disease after infection, and response to antiretroviral therapy all vary by age. In those living with HIV, current effective treatment has increased the median life expectancy to >70 years of age. Biologic, medical, individual, social, and societal issues change as one ages with HIV infection, but there has been only a small amount of research in this field. Therefore, the Office of AIDS Research of the National Institutes of Health commissioned a working group to develop an outline of the current state of knowledge and areas of critical need for research in HIV and Aging; the working groups' findings and recommendations are summarized in this report. Key overarching themes identified by the group included the following: multimorbidity, polypharmacy, and the need to emphasize maintenance of function; the complexity of assessing HIV versus treatment effects versus aging versus concurrent disease; the inter-related mechanisms of immune senescence, inflammation, and hypercoagulability; the utility of multivariable indices for predicting outcomes; a need to emphasize human studies to account for complexity; and a required focus on issues of community support, caregivers, and systems infrastructure. Critical resources are needed to enact this research agenda and include expanded review panel expertise in aging, functional measures, and multimorbidity, and facilitated use and continued funding to allow long-term follow-up of cohorts aging with HIV.

Original languageEnglish (US)
JournalJournal of Acquired Immune Deficiency Syndromes
Volume60
Issue numberSUPPL.1
DOIs
StatePublished - Jul 1 2012

Fingerprint

Acquired Immunodeficiency Syndrome
HIV
Research
Comorbidity
Polypharmacy
Thrombophilia
National Institutes of Health (U.S.)
Risk-Taking
Life Expectancy
Caregivers
HIV Infections
Disease Progression
Therapeutics
Maintenance
Inflammation
Infection

Keywords

  • aging
  • co-morbidity
  • HIV/AIDS
  • research priorities

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

HIV and aging : State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group. / High, Kevin P.; Brennan-Ing, Mark; Clifford, David B.; Cohen, Mardge H.; Currier, Judith; Deeks, Steven G.; Deren, Sherry; Effros, Rita B.; Gebo, Kelly; Goronzy, Jörg J.; Justice, Amy C.; Landay, Alan; Levin, Jules; Miotti, Paolo G.; Munk, Robert J.; Nass, Heidi; Rinaldo, Charles R.; Shlipak, Michael G.; Tracy, Russell; Valcour, Victor; Vance, David E.; Walston, Jeremy D; Volberding, Paul.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 60, No. SUPPL.1, 01.07.2012.

Research output: Contribution to journalArticle

High, KP, Brennan-Ing, M, Clifford, DB, Cohen, MH, Currier, J, Deeks, SG, Deren, S, Effros, RB, Gebo, K, Goronzy, JJ, Justice, AC, Landay, A, Levin, J, Miotti, PG, Munk, RJ, Nass, H, Rinaldo, CR, Shlipak, MG, Tracy, R, Valcour, V, Vance, DE, Walston, JD & Volberding, P 2012, 'HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group', Journal of Acquired Immune Deficiency Syndromes, vol. 60, no. SUPPL.1. https://doi.org/10.1097/QAI.0b013e31825a3668
High, Kevin P. ; Brennan-Ing, Mark ; Clifford, David B. ; Cohen, Mardge H. ; Currier, Judith ; Deeks, Steven G. ; Deren, Sherry ; Effros, Rita B. ; Gebo, Kelly ; Goronzy, Jörg J. ; Justice, Amy C. ; Landay, Alan ; Levin, Jules ; Miotti, Paolo G. ; Munk, Robert J. ; Nass, Heidi ; Rinaldo, Charles R. ; Shlipak, Michael G. ; Tracy, Russell ; Valcour, Victor ; Vance, David E. ; Walston, Jeremy D ; Volberding, Paul. / HIV and aging : State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group. In: Journal of Acquired Immune Deficiency Syndromes. 2012 ; Vol. 60, No. SUPPL.1.
@article{ec700434cc6b46b0bedb49c200f2c53b,
title = "HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group",
abstract = "HIV risk behaviors, susceptibility to HIV acquisition, progression of disease after infection, and response to antiretroviral therapy all vary by age. In those living with HIV, current effective treatment has increased the median life expectancy to >70 years of age. Biologic, medical, individual, social, and societal issues change as one ages with HIV infection, but there has been only a small amount of research in this field. Therefore, the Office of AIDS Research of the National Institutes of Health commissioned a working group to develop an outline of the current state of knowledge and areas of critical need for research in HIV and Aging; the working groups' findings and recommendations are summarized in this report. Key overarching themes identified by the group included the following: multimorbidity, polypharmacy, and the need to emphasize maintenance of function; the complexity of assessing HIV versus treatment effects versus aging versus concurrent disease; the inter-related mechanisms of immune senescence, inflammation, and hypercoagulability; the utility of multivariable indices for predicting outcomes; a need to emphasize human studies to account for complexity; and a required focus on issues of community support, caregivers, and systems infrastructure. Critical resources are needed to enact this research agenda and include expanded review panel expertise in aging, functional measures, and multimorbidity, and facilitated use and continued funding to allow long-term follow-up of cohorts aging with HIV.",
keywords = "aging, co-morbidity, HIV/AIDS, research priorities",
author = "High, {Kevin P.} and Mark Brennan-Ing and Clifford, {David B.} and Cohen, {Mardge H.} and Judith Currier and Deeks, {Steven G.} and Sherry Deren and Effros, {Rita B.} and Kelly Gebo and Goronzy, {J{\"o}rg J.} and Justice, {Amy C.} and Alan Landay and Jules Levin and Miotti, {Paolo G.} and Munk, {Robert J.} and Heidi Nass and Rinaldo, {Charles R.} and Shlipak, {Michael G.} and Russell Tracy and Victor Valcour and Vance, {David E.} and Walston, {Jeremy D} and Paul Volberding",
year = "2012",
month = "7",
day = "1",
doi = "10.1097/QAI.0b013e31825a3668",
language = "English (US)",
volume = "60",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL.1",

}

TY - JOUR

T1 - HIV and aging

T2 - State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group

AU - High, Kevin P.

AU - Brennan-Ing, Mark

AU - Clifford, David B.

AU - Cohen, Mardge H.

AU - Currier, Judith

AU - Deeks, Steven G.

AU - Deren, Sherry

AU - Effros, Rita B.

AU - Gebo, Kelly

AU - Goronzy, Jörg J.

AU - Justice, Amy C.

AU - Landay, Alan

AU - Levin, Jules

AU - Miotti, Paolo G.

AU - Munk, Robert J.

AU - Nass, Heidi

AU - Rinaldo, Charles R.

AU - Shlipak, Michael G.

AU - Tracy, Russell

AU - Valcour, Victor

AU - Vance, David E.

AU - Walston, Jeremy D

AU - Volberding, Paul

PY - 2012/7/1

Y1 - 2012/7/1

N2 - HIV risk behaviors, susceptibility to HIV acquisition, progression of disease after infection, and response to antiretroviral therapy all vary by age. In those living with HIV, current effective treatment has increased the median life expectancy to >70 years of age. Biologic, medical, individual, social, and societal issues change as one ages with HIV infection, but there has been only a small amount of research in this field. Therefore, the Office of AIDS Research of the National Institutes of Health commissioned a working group to develop an outline of the current state of knowledge and areas of critical need for research in HIV and Aging; the working groups' findings and recommendations are summarized in this report. Key overarching themes identified by the group included the following: multimorbidity, polypharmacy, and the need to emphasize maintenance of function; the complexity of assessing HIV versus treatment effects versus aging versus concurrent disease; the inter-related mechanisms of immune senescence, inflammation, and hypercoagulability; the utility of multivariable indices for predicting outcomes; a need to emphasize human studies to account for complexity; and a required focus on issues of community support, caregivers, and systems infrastructure. Critical resources are needed to enact this research agenda and include expanded review panel expertise in aging, functional measures, and multimorbidity, and facilitated use and continued funding to allow long-term follow-up of cohorts aging with HIV.

AB - HIV risk behaviors, susceptibility to HIV acquisition, progression of disease after infection, and response to antiretroviral therapy all vary by age. In those living with HIV, current effective treatment has increased the median life expectancy to >70 years of age. Biologic, medical, individual, social, and societal issues change as one ages with HIV infection, but there has been only a small amount of research in this field. Therefore, the Office of AIDS Research of the National Institutes of Health commissioned a working group to develop an outline of the current state of knowledge and areas of critical need for research in HIV and Aging; the working groups' findings and recommendations are summarized in this report. Key overarching themes identified by the group included the following: multimorbidity, polypharmacy, and the need to emphasize maintenance of function; the complexity of assessing HIV versus treatment effects versus aging versus concurrent disease; the inter-related mechanisms of immune senescence, inflammation, and hypercoagulability; the utility of multivariable indices for predicting outcomes; a need to emphasize human studies to account for complexity; and a required focus on issues of community support, caregivers, and systems infrastructure. Critical resources are needed to enact this research agenda and include expanded review panel expertise in aging, functional measures, and multimorbidity, and facilitated use and continued funding to allow long-term follow-up of cohorts aging with HIV.

KW - aging

KW - co-morbidity

KW - HIV/AIDS

KW - research priorities

UR - http://www.scopus.com/inward/record.url?scp=84864276304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864276304&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e31825a3668

DO - 10.1097/QAI.0b013e31825a3668

M3 - Article

VL - 60

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - SUPPL.1

ER -